Neurocrine Bioscience buy Barclays PLC
Start price
23.01.24
/
50%
€129.15
Target price
23.01.25
€137.96
Performance (%)
-5.42%
Price
06.06.24
€122.15
Summary
This prediction is currently active. With a performance of -5.42%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 23.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -3.209% | -3.209% |
iShares Core DAX® | 0.805% | 2.118% |
iShares Nasdaq 100 | 1.995% | 4.071% |
iShares Nikkei 225® | 1.264% | -2.374% |
iShares S&P 500 | 1.637% | 2.287% |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Barclays PLC from $145.00 to $150.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€157.54
02.05.25
02.05.25
-6.93%
06.06.24
06.06.24